Valo Health Company

Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reduce cost, time, and failure rate. The company's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development, that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration.
Technology: Biotechnology, Health Care, Medical
Industry: Early Drug Development
Headquarters: Boston, Massachusetts, United States
Founded Date: 2019-01-01
Employees Number: 101-250
Funding Status: Early Stage Venture
Acquisitions Number: 2
Investors Number: 9
Total Funding: 460000000
Last Funding Date: 2021-03-09
Last Funding Type: Series B

Visit Website
partnerships@valohealth.com
https://twitter.com/valohealth
Register and Claim Ownership